Mechanistic description
Cerebral amyloid angiopathy (CAA) maintains a reservoir of vascular amyloid that continues to drive tau pathology even after parenchymal amyloid clearance. CSF p-tau217 may not fully normalize in patients with CAA, meaning p-tau217-based cessation thresholds require composite criteria incorporating CAA biomarkers (CAA-lobular microbleeds, vessel wall imaging) to prevent premature cessation. APOE ε4 carriers show delayed p-tau217 normalization due to enhanced vascular amyloid deposition that resists anti-Aβ antibody penetration.
Evidence for (4)
APOE ε4 carriers show delayed p-tau217 normalization due to enhanced CAA burden
Vascular amyloid deposits resist anti-Aβ antibody penetration and clearance
Mixed amyloid pathologies complicate biomarker-based treatment cessation decisions
MRI SWI and vessel wall imaging can identify high-risk CAA features for patient stratification
Evidence against (3)
APOE ε4 effects on p-tau217 may be independent of CAA rather than mediated by vascular amyloid
CAA burden does not consistently predict cognitive trajectory in anti-amyloid antibody trials
Degree of incomplete p-tau217 normalization attributable to CAA versus other factors unquantified
Evidence matrix
Supporting
- APOE ε4 carriers show delayed p-tau217 normalization due to enhanced CAA burden PMID:37106692
- Vascular amyloid deposits resist anti-Aβ antibody penetration and clearance PMID:32084328
- Mixed amyloid pathologies complicate biomarker-based treatment cessation decisions PMID:36539417
- MRI SWI and vessel wall imaging can identify high-risk CAA features for patient stratification PMID:none cited but standard clinical imaging
Contradicting
- APOE ε4 effects on p-tau217 may be independent of CAA rather than mediated by vascular amyloid PMID:37106692
- CAA burden does not consistently predict cognitive trajectory in anti-amyloid antibody trials PMID:none cited
- Degree of incomplete p-tau217 normalization attributable to CAA versus other factors unquantified PMID:none cited
Cite this hypothesis
Cite this hypothesis
etl-backfill (2026). Residual Vascular Amyloid Prevents Complete CSF p-tau217 Normalization, Requiri…. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-SDA-2026-04-26-gap-debate-20260417-033134-20519caa-01-residual-vascular-amyloid-prevents-complete-csf--ed8812948d
@misc{scidex_hypothesis_hsda2026,
title = {Residual Vascular Amyloid Prevents Complete CSF p-tau217 Normalization, Requiri…},
author = {etl-backfill},
year = {2026},
howpublished = {SciDEX hypothesis},
url = {https://prism.scidex.ai/hypotheses/h-SDA-2026-04-26-gap-debate-20260417-033134-20519caa-01-residual-vascular-amyloid-prevents-complete-csf--ed8812948d},
note = {SciDEX artifact hypothesis:h-SDA-2026-04-26-gap-debate-20260417-033134-20519caa-01-residual-vascular-amyloid-prevents-complete-csf--ed8812948d}
}